Main

related bits

0

processing priority

4

site type

3 (personal blog or private political site, e.g. Blogspot, Substack, also small blogs on own domains)

review version

11

html import

20 (imported)

Events

first seen date

2025-03-23 04:46:48

expired found date

-

created at

2025-03-23 04:46:48

updated at

2026-01-08 00:38:47

Domain name statistics

length

23

crc

43920

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

13642151 (wordpress.com)

previous id

0

replaced with id

0

related id

-

dns primary id

0

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

1

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2025-03-26 02:23:24

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

219827

mp size raw text

41323

mp inner links count

24

mp inner links status

20 (imported)

Open Graph

title

Med.Chem.Cool

description

Medicinal Chemistry and Drug Development Information

image

site name

Med.Chem.Cool

author

updated

2026-01-04 11:28:44

raw text

Med.Chem.Cool | Medicinal Chemistry and Drug Development Information Med.Chem.Cool Medicinal Chemistry and Drug Development Information Main menu Skip to content Home About Search GO June 6, 2013 Tasimelteon Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder  WASHINGTON, June 5, 2013 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals. Non-24 is a serious, rare and chronic circadian rhythm disorder that affects a majority of totally blind individuals who lack light perception and cann...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

spam phrases

1

Text statistics

text nonlatin

3

text cyrillic

0

text characters

33146

text words

5987

text unique words

1726

text lines

442

text sentences

272

text paragraphs

76

text words per sentence

22

text matched phrases

28

text matched dictionaries

14

RSS

rss status

32 (unknown)

rss found date

2025-03-23 04:46:49

rss size orig

53460

rss items

10

rss spam phrases

1

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

40 (completed successful import of reports.txt file to table in_pages)

sitemap review version

2

sitemap urls count

19

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2025-03-23 04:46:48

sitemap process date

2025-03-30 10:55:00

sitemap first import date

-

sitemap last import date

2025-04-30 14:03:48